Sfoglia per Autore
Cw6 but not allele LCE3C_LCE3B deletion confers sensitivity to ustekinumab treatment in psoriasis
2012-09-01 Botti, E; Talamonti, M; Spallone, G; Galluzzo, M; Bavetta, M; Teoli, M; Pinetti, V; Costanzo, A
Next generation sequencing technology to explore anti-inflammatory activity of IKKa in psoriasis
2012-09-01 Spallone, G; Botti, E; Talamonti, M; Marinari, B; Pinetti, V; Chimenti, S; Costanzo, A
Genetic variations in IL6 and IL12B as protective markers for psoriasis
2013-01-01 Boca, An; Talamonti, M; Galluzzo, M; Botti, E; Buzoianu, Ad; Costanzo, A
Living matter observations with a novel hyperspectral supercontinuum confocal microscope for VIS to near-IR reflectance spectroscopy
2013-01-01 Bertani, Fr; Ferrari, L; Mussi, V; Botti, E; Costanzo, A; Selci, S
Etanercept reverses downregulation of inhibitor of nuclear factor kappa-B kinase subunit alpha (IKKa) in psoriasis
2013-01-01 Spallone, G; Botti, E; Pinetti, V; Bavetta, M; Pavlidis, A; Chimenti, S; Costanzo, A
Potential role of HLA-Cw6 in clinical response to anti-tumour necrosis factor alpha and t-cell targeting agents in psoriasis patients
2013-01-01 Talamonti, M; Galluzzo, M; Botti, E; Pavlidis, A; Spallone, G; Chimenti, S; Costanzo, A
Genetic variations in IL6 and IL12B decreasing the risk for psoriasis
2013-01-01 Boca, An; Talamonti, M; Galluzzo, M; Botti, E; Vesa, Tc; Chimenti, S; Buzoianu, Ad; Costanzo, A
Genetic variati ons in IL6 and IL12B as protecti ve markers for psoriasis Abstracts of the 2013 International Investigative Dermatology Meeting. May 8-11, 2013. Edinburgh, Scotland, United Kingdom
2013-05-01 Boca, A; Talamonti, M; Galluzzo, M; Botti, E; Buzoianu, A; Costanzo., A
Pharmacogenetics of psoriasis: HLA-Cw6 but not LCE3B/3C deletion nor TNFAIP3 polymorphism predisposes to clinical response to interleukin 12/23 blocker ustekinumab
2013-08-01 Talamonti, M; Botti, E; Galluzzo, M; Teoli, M; Spallone, G; Bavetta, M; Chimenti, S; Costanzo, A
Human leucocyte antigen Cw6 predisposes to clinical response to the inlterleukin-12/23 blocker ustekinumab: results of long-term treatment
2014-01-01 Talamonti, M; Galluzzo, M; Botti, E; Chimenti, S; Costanzo, A
TP63 and TP73 in cancer, an unresolved "family" puzzle of complexity, redundancy and hierarchy
2014-01-01 Costanzo, A; Pediconi, N; Narcisi, A; Guerrieri, F; Belloni, L; Fausti, F; Botti, E; Levrero, M
The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis
2014-01-01 Lande, R; Botti, E; Jandus, C; Dojcinovic, D; Fanelli, G; Conrad, C; Chamilos, G; Feldmeyer, L; Marinari, B; Chon, S; Vence, L; Riccieri, V; Guillaume, P; Navarini, Aa; Romero, P; Costanzo, A; Piccolella, E; Gilliet, M; Frasca, L
Detection of adalimumab and anti-adalimumab levels by ELISA: clinical considerations
2014-11-01 Marinari, B; Botti, E; Bavetta, M; Spallone, G; Zangrilli, A; Talamonti, M; Richetta, A; Chimenti, S; Costanzo, A
Severe erytrodermic psoriasis in child twins: From clinical-pathological diagnosis to treatment of choice through genetic analyses: Two case reports
2014-12-01 Campione, E; Diluvio, L; Terrinoni, A; Orlandi, A; Latino, M; Torti, C; Pietroleonardo, L; Botti, E; Chimenti, S; Bianchi, L
HLACw6 predisposes to clinical response to IL12/23 blocker ustekinumab: Results of short- and long-term treatment in anti-TNF naïve patients
2015-01-01 Talamonti, M; Galluzzo, M; Botti, E; Costanzo, A; Chimenti, S
Programmed cell death in the skin
2015-01-01 Costanzo, A; Fausti, F; Spallone, G; Moretti, F; Narcisi, A; Botti, E
Genetic markers predictive of clinical response to biological drugs in psoriasis.
2015-12-01 Marinari, B; Talamonti, M; Costanzo, A; Botti, E
Functionalized gold nanoparticles for topical delivery of methotrexate for the possible treatment of psoriasis
2016-01-01 Bessar, H; Venditti, I; Benassi, L; Vaschieri, C; Azzoni, P; Pellacani, G; Magnoni, C; Botti, E; Casagrande, V; Federici, M; Costanzo, A; Fontana, L; Testa, G; Mostafa, F; Ibrahim, S; Russo, M; Fratoddi, I
IL12B (p40) Gene Polymorphisms Contribute to Ustekinumab Response Prediction in Psoriasis
2016-01-01 Galluzzo, M; Boca, An; Botti, E; Potenza, C; Malara, G; Malagoli, P; Vesa, S; Chimenti, S; Buzoianu, Ad; Talamonti, M; Costanzo, A
Label-free and non-invasive discrimination of HaCaT and melanoma cells in a co-culture model by hyperspectral confocal reflectance microscopy
2016-01-01 Bertani, Fr; Botti, E; Ferrari, L; Mussi, V; Costanzo, A; D'Alessandro, M; Cilloco, F; Selci, S
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-set-2012 | Cw6 but not allele LCE3C_LCE3B deletion confers sensitivity to ustekinumab treatment in psoriasis | Botti, E; Talamonti, M; Spallone, G; Galluzzo, M; Bavetta, M; Teoli, M; Pinetti, V; Costanzo, A | Intervento a convegno | |
| 1-set-2012 | Next generation sequencing technology to explore anti-inflammatory activity of IKKa in psoriasis | Spallone, G; Botti, E; Talamonti, M; Marinari, B; Pinetti, V; Chimenti, S; Costanzo, A | Intervento a convegno | |
| 1-gen-2013 | Genetic variations in IL6 and IL12B as protective markers for psoriasis | Boca, An; Talamonti, M; Galluzzo, M; Botti, E; Buzoianu, Ad; Costanzo, A | Intervento a convegno | |
| 1-gen-2013 | Living matter observations with a novel hyperspectral supercontinuum confocal microscope for VIS to near-IR reflectance spectroscopy | Bertani, Fr; Ferrari, L; Mussi, V; Botti, E; Costanzo, A; Selci, S | Articolo su rivista | |
| 1-gen-2013 | Etanercept reverses downregulation of inhibitor of nuclear factor kappa-B kinase subunit alpha (IKKa) in psoriasis | Spallone, G; Botti, E; Pinetti, V; Bavetta, M; Pavlidis, A; Chimenti, S; Costanzo, A | Articolo su rivista | |
| 1-gen-2013 | Potential role of HLA-Cw6 in clinical response to anti-tumour necrosis factor alpha and t-cell targeting agents in psoriasis patients | Talamonti, M; Galluzzo, M; Botti, E; Pavlidis, A; Spallone, G; Chimenti, S; Costanzo, A | Articolo su rivista | |
| 1-gen-2013 | Genetic variations in IL6 and IL12B decreasing the risk for psoriasis | Boca, An; Talamonti, M; Galluzzo, M; Botti, E; Vesa, Tc; Chimenti, S; Buzoianu, Ad; Costanzo, A | Articolo su rivista | |
| 1-mag-2013 | Genetic variati ons in IL6 and IL12B as protecti ve markers for psoriasis Abstracts of the 2013 International Investigative Dermatology Meeting. May 8-11, 2013. Edinburgh, Scotland, United Kingdom | Boca, A; Talamonti, M; Galluzzo, M; Botti, E; Buzoianu, A; Costanzo., A | Intervento a convegno | |
| 1-ago-2013 | Pharmacogenetics of psoriasis: HLA-Cw6 but not LCE3B/3C deletion nor TNFAIP3 polymorphism predisposes to clinical response to interleukin 12/23 blocker ustekinumab | Talamonti, M; Botti, E; Galluzzo, M; Teoli, M; Spallone, G; Bavetta, M; Chimenti, S; Costanzo, A | Articolo su rivista | |
| 1-gen-2014 | Human leucocyte antigen Cw6 predisposes to clinical response to the inlterleukin-12/23 blocker ustekinumab: results of long-term treatment | Talamonti, M; Galluzzo, M; Botti, E; Chimenti, S; Costanzo, A | Intervento a convegno | |
| 1-gen-2014 | TP63 and TP73 in cancer, an unresolved "family" puzzle of complexity, redundancy and hierarchy | Costanzo, A; Pediconi, N; Narcisi, A; Guerrieri, F; Belloni, L; Fausti, F; Botti, E; Levrero, M | Articolo su rivista | |
| 1-gen-2014 | The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis | Lande, R; Botti, E; Jandus, C; Dojcinovic, D; Fanelli, G; Conrad, C; Chamilos, G; Feldmeyer, L; Marinari, B; Chon, S; Vence, L; Riccieri, V; Guillaume, P; Navarini, Aa; Romero, P; Costanzo, A; Piccolella, E; Gilliet, M; Frasca, L | Articolo su rivista | |
| 1-nov-2014 | Detection of adalimumab and anti-adalimumab levels by ELISA: clinical considerations | Marinari, B; Botti, E; Bavetta, M; Spallone, G; Zangrilli, A; Talamonti, M; Richetta, A; Chimenti, S; Costanzo, A | Articolo su rivista | |
| 1-dic-2014 | Severe erytrodermic psoriasis in child twins: From clinical-pathological diagnosis to treatment of choice through genetic analyses: Two case reports | Campione, E; Diluvio, L; Terrinoni, A; Orlandi, A; Latino, M; Torti, C; Pietroleonardo, L; Botti, E; Chimenti, S; Bianchi, L | Articolo su rivista | |
| 1-gen-2015 | HLACw6 predisposes to clinical response to IL12/23 blocker ustekinumab: Results of short- and long-term treatment in anti-TNF naïve patients | Talamonti, M; Galluzzo, M; Botti, E; Costanzo, A; Chimenti, S | Intervento a convegno | |
| 1-gen-2015 | Programmed cell death in the skin | Costanzo, A; Fausti, F; Spallone, G; Moretti, F; Narcisi, A; Botti, E | Articolo su rivista | |
| 1-dic-2015 | Genetic markers predictive of clinical response to biological drugs in psoriasis. | Marinari, B; Talamonti, M; Costanzo, A; Botti, E | Brevetti | |
| 1-gen-2016 | Functionalized gold nanoparticles for topical delivery of methotrexate for the possible treatment of psoriasis | Bessar, H; Venditti, I; Benassi, L; Vaschieri, C; Azzoni, P; Pellacani, G; Magnoni, C; Botti, E; Casagrande, V; Federici, M; Costanzo, A; Fontana, L; Testa, G; Mostafa, F; Ibrahim, S; Russo, M; Fratoddi, I | Articolo su rivista | |
| 1-gen-2016 | IL12B (p40) Gene Polymorphisms Contribute to Ustekinumab Response Prediction in Psoriasis | Galluzzo, M; Boca, An; Botti, E; Potenza, C; Malara, G; Malagoli, P; Vesa, S; Chimenti, S; Buzoianu, Ad; Talamonti, M; Costanzo, A | Articolo su rivista | |
| 1-gen-2016 | Label-free and non-invasive discrimination of HaCaT and melanoma cells in a co-culture model by hyperspectral confocal reflectance microscopy | Bertani, Fr; Botti, E; Ferrari, L; Mussi, V; Costanzo, A; D'Alessandro, M; Cilloco, F; Selci, S | Articolo su rivista |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile